US 10835517
Methods for treating ocular demodex using isoxazoline parasiticide formulations
granted A61KA61K31/42A61K31/422
Quick answer
US patent 10835517 (Methods for treating ocular demodex using isoxazoline parasiticide formulations) held by Tarsus Pharmaceuticals, Inc. expires Mon Nov 12 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Tarsus Pharmaceuticals, Inc.
- Grant date
- Tue Nov 17 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 12 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 28
- CPC classes
- A61K, A61K31/42, A61K31/422, A61K47/26, A61K9/0048